Literature DB >> 15728330

Pharmacists' participation in an inhaled respiratory medication program: reimbursement of professional fees.

Andrea L Murphy1, Neil J MacKinnon, Priti S Flanagan, Susan K Bowles, Ingrid S Sketris.   

Abstract

BACKGROUND: An intervention (termed Initiative) was initiated to facilitate converting beneficiaries of a public drug insurance program in the province of Nova Scotia from respiratory nebulization medications to inhalers. Community pharmacists provided patient education and billed professional fees for conversions or optimizing inhaled respiratory medication technique.
OBJECTIVE: To determine community pharmacists' self-reported participation rate and identify facilitators and barriers to billing for professional fees.
METHODS: A survey was developed and mailed to Nova Scotia pharmacists. Information on demographics, work environment, professional experience, financial aspects, billing experiences, and the billing process was collected. Quantitative and qualitative data were evaluated using bivariate and multivariate analyses, and a thematic process, respectively.
RESULTS: Two hundred ninety-seven pharmacists responded. Self-reported billing rates for fees were 34% (switching delivery devices), 58% (optimizing AeroChamber use), and 37% (follow-up when replacing Aerochambers). Awareness of fees and the perception of consistent claim reimbursement were associated with billing for each fee (p < 0.05). Predisposing billing factors included awareness of fees, identifying situations requiring education, owner/manager position, male gender, perception that billing for education for optimizing technique is a minimum standard of practice, and prescription volume. Themes identified as barriers included inefficient billing process, inadequate fees, and lack of Initiative awareness.
CONCLUSIONS: Predisposing factors were the most important facilitators of community pharmacists' participation in this program, while a cumbersome and time-consuming billing process was the primary barrier. Further research should determine the impact of the professional fee on patient health outcomes.

Entities:  

Mesh:

Year:  2005        PMID: 15728330     DOI: 10.1345/aph.1E286

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  4 in total

1.  Participants' perceptions of a multidisciplinary training program for graduate and postgraduate students in drug use management and policy.

Authors:  Patricia Conrad; Ingrid Sketris; Ethel Langille-Ingram
Journal:  Am J Pharm Educ       Date:  2013-06-12       Impact factor: 2.047

2.  Development of a qualitative exploratory case study research method to explore sustained delivery of cognitive services.

Authors:  Susanne Kaae; Birthe Søndergaard; Lotte Stig Haugbølle; Janine Morgall Traulsen
Journal:  Pharm World Sci       Date:  2009-10-13

3.  Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study.

Authors:  Julien Marquis; Marie P Schneider; Brenda Spencer; Olivier Bugnon; Sophie Du Pasquier
Journal:  Int J Clin Pharm       Date:  2014-08-20

4.  Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.

Authors:  Laura V Minard; Heidi Deal; Megan E Harrison; Kent Toombs; Heather Neville; Andrea Meade
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.